In November, the National Research Council selected InnerVision to receive an Industrial Research Assistance Program grant of $203,500 over the next nine months. The non-repayable grant required extensive due diligence on the part of the National Research Council. The grant supports the final technical development activities required to commercialize Flash UltraSound™.

In October, Alberta Ingenuity Fund, through the Industrial Associate Program, awarded InnerVision funding of $110,000 over two years. This award supports the research efforts of one of InnerVision's Ph.D. scientists, Dr. Jeffrey Grossman, and accelerates our efforts in the area of tissue characterization and, ultimately, cancer diagnosis.

AuntMinnie.com Editor In Chief, Brian Casey introduces InnerVision as a promising new technology: "InnerVision Medical Technologies hopes its Flash Ultrasound will result in a quantum leap in ultrasound resolution that will propel the modality into new applications. Due to Flash Ultrasound's origins in technology used to detect oil fields through bedrock, it holds promise for the visualization of hard structures such as bone and microcalcifications in breast tissue.

"InnerVision also has a novel concept for image acquisition and processing, with the firm planning to roll out less expensive data acquisitions systems that are hooked into a powerful central processing computer." View the full article by Robert Bruce.

InnerVision filed a patent application titled Determining Attributes Using Ultrasound to the U.S. patent office and international Patent Cooperation Treaty on September 20, 2004. The patent claims advanced capabilities for determining tissue attributes using ultrasound energy. The U.S. based, IP and patent law firm, Knobbe Martens Olson & Bear LLP are representing InnerVision.

The Alberta Heritage Foundation for Medical Research profiled InnerVision in its Spring Newsletter focusing on Cancer. Tim Davies and Richard Evans saw an opportunity—a way to dramatically improve ultrasound imaging, making it faster and more accurate. Their acoustic-based technology holds the promise of affordable disease screening. View full article.

InnerVision filed an international patent application titled Systems and Methods for Improving Imaging with the international Patent Cooperation Treaty on March 8, 2005. The patent claims a resolution capability significantly greater than existing ultrasound technologies, and proprietary techniques and algorithms that enable acoustic analysis beyond what acoustic science has historically achieved. These same capabilities are included in the U.S. Patent Application submitted by InnerVision in September 20, 2004, The U.S. based, IP and patent law firm, Knobbe Martens Olson & Bear LLP are representing InnerVision.

InnerVision is pleased to announce the formation of and initial appointments to our Scientific Advisory Board. Dr. Stuart Nicholson, M.D. and Dr. Michael Halliwell, Ph.D. joined this board effective October 15, 2004. Dr. Nicholson is a diagnostic radiologist with more than 30 years clinical experience and is widely published in the area of fetal, maternal and cardiac ultrasound. Dr. Halliwell has spent the last 40 years studying and advancing the field of medical ultrasound imaging. He currently holds the position of Senior Research Fellow at the University of Bristol Centre for Physics and Engineering in Medicine. Dr. Halliwell is widely published and recognized internationally as both an expert and thought leader in ultrasound imaging.

InnerVision filed a U.S Patent Application titled Systems and Methods for Improving Imaging on September 20, 2004. The patent claims a resolution capability significantly greater than existing ultrasound technologies, and proprietary techniques and algorithms that enable acoustic analysis beyond what acoustic science has historically achieved. The U.S. based, IP and patent law firm, Knobbe Martens Olson & Bear LLP are representing InnerVision.